ÌÇÐÄvlog´«Ã½

Europe Epigenetics Market Report - Table of Contents

1. 1. INTRODUCTION

   1. 1.1 Study Deliverables

   2. 1.2 Study Assumptions

   3. 1.3 Scope of the Study

2. 2. RESEARCH METHODOLOGY

3. 3. EXECUTIVE SUMMARY

4. 4. MARKET DYNAMICS

   1. 4.1 Market Overview

   2. 4.2 Market Drivers

      1. 4.2.1 Increasing Incidence and Prevalence of Cancer

      2. 4.2.2 Increasing Funding for R&D in Healthcare

      3. 4.2.3 Rising Epigenetic Applications in Non-Oncology Diseases

   3. 4.3 Market Restraints

      1. 4.3.1 Rising Cost of Instruments

      2. 4.3.2 Dearth of Skilled Researchers

   4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

5. 5. MARKET SEGMENTATION

   1. 5.1 By Product

      1. 5.1.1 By Kits

         1. 5.1.1.1 Bisulfite Conversion Kits

         2. 5.1.1.2 Chip-seq Kits

         3. 5.1.1.3 RNA Sequencing Market

         4. 5.1.1.4 Whole Genome Amplification Market

         5. 5.1.1.5 5-HMC and 5-MC Analysis Kits

         6. 5.1.1.6 Other Kits

      2. 5.1.2 By Reagents

         1. 5.1.2.1 Antibodies

         2. 5.1.2.2 Buffers

         3. 5.1.2.3 Histones

         4. 5.1.2.4 Magnetic Beads

         5. 5.1.2.5 Primers

         6. 5.1.2.6 Other Reagents

      3. 5.1.3 By Enzymes

         1. 5.1.3.1 DNA - Modifying Enzymes

         2. 5.1.3.2 Protein Modifying Enzymes

         3. 5.1.3.3 RNA Modifying Enzymes

      4. 5.1.4 By Instruments

         1. 5.1.4.1 Mass Spectrometer

         2. 5.1.4.2 Sonicators

         3. 5.1.4.3 Next Generation Sequencers

         4. 5.1.4.4 Other Instruments

   2. 5.2 By Application

      1. 5.2.1 Oncology

      2. 5.2.2 Non-Oncology

         1. 5.2.2.1 Inflammatory Diseases

         2. 5.2.2.2 Metabolic Diseases

         3. 5.2.2.3 Infectious Diseases

         4. 5.2.2.4 Cardiovascular Diseases

         5. 5.2.2.5 Other Non-Oncology Applications

      3. 5.2.3 Developmental Biology

      4. 5.2.4 Other Research Areas

   3. 5.3 By Technology

      1. 5.3.1 DNA Methylation

      2. 5.3.2 Histone Methylation

      3. 5.3.3 Histone Acetylation

      4. 5.3.4 Large noncoding RNA

      5. 5.3.5 MicroRNA modification

      6. 5.3.6 Chromatin Structures

   4. 5.4 Geography

      1. 5.4.1 Europe

         1. 5.4.1.1 Germany

         2. 5.4.1.2 UK

         3. 5.4.1.3 France

         4. 5.4.1.4 Italy

         5. 5.4.1.5 Spain

         6. 5.4.1.6 Rest of Europe

6. 6. COMPETITIVE LANDSCAPE

   1. 6.1 Company Profiles

      1. 6.1.1 Diagenode Inc.

      2. 6.1.2 Epitherapeutics

      3. 6.1.3 Illumina, Inc.

      4. 6.1.4 Merck & Co.

      5. 6.1.5 Qiagen

      6. 6.1.6 F. Hoffmann-La Roche AG

      7. 6.1.7 Thermo Fisher Scientific

      8. 6.1.8 Zymo Research Corporation

   2. *List Not Exhaustive

7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS